Arthramid Vet (2.5% polyacrylamide hydrogel) – formulation, mode of action, published research, indications for use, dose rate, post-injection protocols

They outline the formulation of the product and give extensive details on its mode of action. The webinar also covers various published research papers over a number of years. Indications for use for Arthramid Vet are explored as well as dose rates and post injection protocols.

Arthramid Vet is registered in New Zealand to: Innovative Medical Solutions Limited NZBN: 9429041325544, 32 Hill Road, Cambridge 3494, New Zealand. Registered pursuant to the ACVM Act 1997 Number A11596.